Home
Reels
Gruplar
Sayfalar
Daha fazla gör
Gruplar Sayfalar Events Blogs Funding
Giriş yapın Başvur
Night Mode
How Are Disease-Modifying Biologics Transforming Pulmonary Arterial Hypertension Treatment?
For decades, PAH treatment relied on vasodilators that managed symptoms but did not address the underlying disease process. Disease-modifying biologics are transforming PAH treatment by targeting the vascular remodeling that drives disease progression, offering the potential for improved long-term outcomes. This innovation is a major driver of growth in the Pulmonary Arterial Hypertension...
0 Yorumlar ·0 hisse senetleri ·135 Views ·0 önizleme
Please log in to like, share and comment!